APA (7th ed.) Citation

Hentzien, M., Bonnet, F., Bernasconi, E., Biver, E., Braun, D. L., Munting, A., . . . Calmy, A. (2024). Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): A multicenter, international, non-randomized clinical trial study protocol. BMC Infectious Diseases, 24(1), 1. https://doi.org/10.1186/s12879-024-09192-5

Chicago Style (17th ed.) Citation

Hentzien, Maxime, et al. "Immune Response to the Recombinant Herpes Zoster Vaccine in People Living with HIV over 50 Years of Age Compared to Non-HIV Age-/gender-matched Controls (SHINGR'HIV): A Multicenter, International, Non-randomized Clinical Trial Study Protocol." BMC Infectious Diseases 24, no. 1 (2024): 1. https://doi.org/10.1186/s12879-024-09192-5.

MLA (9th ed.) Citation

Hentzien, Maxime, et al. "Immune Response to the Recombinant Herpes Zoster Vaccine in People Living with HIV over 50 Years of Age Compared to Non-HIV Age-/gender-matched Controls (SHINGR'HIV): A Multicenter, International, Non-randomized Clinical Trial Study Protocol." BMC Infectious Diseases, vol. 24, no. 1, 2024, p. 1, https://doi.org/10.1186/s12879-024-09192-5.